Timothy Murphy, MD, FACP, practice president of Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the effect of the COVID-19 pandemic on screening for lung cancer.
Timothy Murphy, MD, FACP, practice president of Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the effect of the pandemic on screening for lung cancer.
Transcript
What impact did COVID-19 and the delay in diagnosis have on the patients with lung cancer who are coming into cancer practices now?
COVID-19 created a significant delay in diagnoses, not just in lung cancer but essentially all cancers across the board is what the data is looking like during the 2 quarters in 2020 where essentially everything was shut down. So, the rate of screening for lung cancer essentially went to zero, and what we're finding now that the system is open and back up and running, we're not getting the same amount of people coming in.
There was a real hesitancy during the end of 2020 and really into 2021 of people going back to the centers to get screened. So, we are not back to prepandemic levels of screening, and more importantly, and rather tragically, the cancers we are now diagnosing, specifically lung cancer, do appear to be in a later stage, likely as a result in the delay of that screening.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Workers Facing Greater Economic Hardship More Likely to Report Poor Health
June 2nd 2025US workers facing high economic hardship, especially those in lower-wage occupations, were significantly more likely to report fair or poor health, underscoring persistent disparities in worker well-being.
Read More